Market leaders in the technology, pharmaceutical and financial services sectors continue to demonstrate confidence by further investing in Ireland…

• Google recently announced plans to invest US$101 million (€75 million) in a new data centre in Dublin, which will rank as one of the most energy efficient centres in the world. This will further establish Ireland as a worldwide location of choice for cloud computing
• Microsoft has been granted planning permission for a 11,090 square metre data centre adjoining its existing data centre at its facility in Dublin
• Dell is to establish a Cloud Research and Development Centre in Dublin and the first of 22 international “Dell Solution Centres” in Limerick. Recruitment is currently underway at both facilities with a total of 150 people expected to be employed across both in the next two years
• Intel has announced it is to locate its global Energy and Sustainability Lab in Ireland at its existing campus close to Dublin
• Twitter, the global social networking giant, has announced plans to establish an international headquarters in Dublin. The office in Dublin will be the third twitter location outside the US
• JRI America Inc plans to establish a software development facility in Tralee, County Kerry which is expected to create 100 highly skilled positions over the next 5 years
• Pivot Acquisition Corp, the North American IT solutions provider, has announced the opening of a Shared Services Centre in Galway to support the company’s rapid international growth and expansion
• BioMarin Pharmaceutical Inc has invested US$48.5 million (€35.6 million) in the purchase of Pfizer’s 133,000 square foot bulk biologics manufacturing facility in Cork. The purchase of the facility is part of the company’s phased expansion into Ireland’s life sciences industry and follows the establishment of an international supply chain and logistics presence in Ireland in early 2011. It will also be the first time the company has placed internal biopharmaceutical production activities outside of the US
• Genzyme, a world leader in biotechnology and pharmaceuticals, has invested a US$203 million (€150 million) in a new facility at its biotechnology campus in Waterford. This brings Genzyme’s total investment since arriving in Ireland ten years ago to US$678 million (€500 million)
• Boston Scientific Corporation, which has been established in Ireland since 1994, is to invest US$35 million (€26 million) in research and development at its Clonmel facility. The investment will enable the company to expand its R&D and technical capabilities in respect of next generation cardiac rhythm management devices manufactured at the Clonmel plant
• BNY Mellon has announced that it is to establish a new company, BNY Mellon Clearing International, in Dublin. The new company will clear listed funds and option trades for EMEA based institutional clients and will create 50 new highly skilled jobs
• Glass Lewis, the leading independent governance services and investment research firm, has opened an office in Limerick which will serve institutional investors throughout Europe. The Limerick office will be the fifth in Glass Lewis’ global network